Laight D W, Woodward B, Waterfall J F
Pharmacology Group, Bath University, Claverton Down.
Inflamm Res. 1995 Mar;44(3):116-20. doi: 10.1007/BF01782021.
The aim of this study was to evaluate the roles of nitric oxide (NO) and prostanoids in vasodilation to histamine in the preconstricted isolated perfused rat kidney. Kidneys were excised from Hypnorm/Hypnovel-anaesthetised Wistar rats and perfused at constant flow in vitro. Renal perfusion pressure was elevated similarly with methoxamine (3 microM) or modified Krebs Henseleit solution containing high KCl (30 mM) and vasodilation to histamine (10, 30 nmol) and papaverine (30, 100 nmol) was then examined before and during perfusion with the NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 0.3 mM) or the cyclo-oxygenase inhibitor, indomethacin (10 microM). Furthermore, the vasodilator response to 30 nmol histamine was examined in the presence of the H2 receptor antagonist, ranitidine (0.1-10 microM). Vasodilation to histamine (10, 30 nmol) was found to be unaffected by L-NAME (0.3 mM) or indomethacin (10 microM), while ranitidine (0.1-10 microM) antagonised vasodilation to 30 nmol histamine with an estimated pA2 of 6.67. Vasodilation to histamine in the isolated perfused rat kidney is therefore probably independent of NO and prostanoids and mediated by H2 receptors.
本研究的目的是评估一氧化氮(NO)和前列腺素类物质在预先收缩的离体灌注大鼠肾脏中对组胺血管舒张作用的影响。从经Hypnorm/Hypnovel麻醉的Wistar大鼠身上切除肾脏,并在体外以恒定流量进行灌注。用甲氧明(3 microM)或含高氯化钾(30 mM)的改良Krebs Henseleit溶液使肾灌注压同样升高,然后在灌注一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME,0.3 mM)或环氧化酶抑制剂吲哚美辛(10 microM)之前和期间,检测对组胺(10、30 nmol)和罂粟碱(30、100 nmol)的血管舒张作用。此外,在H2受体拮抗剂雷尼替丁(0.1 - 10 microM)存在的情况下,检测对30 nmol组胺的血管舒张反应。发现L-NAME(0.3 mM)或吲哚美辛(10 microM)对组胺(10、30 nmol)的血管舒张作用无影响,而雷尼替丁(0.1 - 10 microM)拮抗对30 nmol组胺的血管舒张作用,估计pA2为6.67。因此,离体灌注大鼠肾脏中对组胺的血管舒张作用可能独立于NO和前列腺素类物质,且由H2受体介导。